The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Intelligence in Drug Discovery and Development Market Research Report 2024
Synopsis
Global Artificial Intelligence in Drug Discovery and Development market is projected to reach US$ 8886.6 million in 2029, increasing from US$ 1366 million in 2022, with the CAGR of 30.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Artificial Intelligence in Drug Discovery and Development market research.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.6%, including software, hardware and services.
China and the United States are two leaders in AI industry. On the AI 100 list (2022) released by CB Insights, the number of companies in the United States ranks first, with more than 70 companies, followed by the United Kingdom, with 8 companies on the list. China and Canada both holds 5 companies on the list. According to data from the China Academy of Information and Communications Technology, the scale of China's core artificial intelligence industry reached ¥508 billion in 2022, a year-on-year increase of 18%. From 2013 to November 2022, the cumulative number of patent applications for artificial intelligence inventions in the world reached 729,000, and the cumulative number of applications in China reached 389,000, accounting for 53.4%. However, the Global Artificial Intelligence Innovation Index Report 2021 released by the China Institute of Scientific and Technological Information shows that the overall strength of the United States is still far ahead. The number of artificial intelligence companies in the United States is about 4,670, while China has only 880. China's data center is less than 1/20 of that of the United States.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Artificial Intelligence in Drug Discovery and Development market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
IBM
Exscientia
Google(Alphabet)
Microsoft
Atomwise
Schrodinger
Aitia
Insilico Medicine
NVIDIA
XtalPi
BPGbio
Owkin
CytoReason
Deep Genomics
Cloud Pharmaceuticals
BenevolentAI
Cyclica
Verge Genomics
Valo Health
Envisagenics
Euretos
BioAge Labs
Iktos
BioSymetrics
Evaxion Biotech
Aria Pharmaceuticals, Inc
Segment by Type
Hardware
Software
Service
Segment by Application
Early Drug Discovery
Preclinical Phase
Clinical Phase
Regulatory Approval
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Artificial Intelligence in Drug Discovery and Development report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Global Artificial Intelligence in Drug Discovery and Development market is projected to reach US$ 8886.6 million in 2029, increasing from US$ 1366 million in 2022, with the CAGR of 30.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Artificial Intelligence in Drug Discovery and Development market research.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.6%, including software, hardware and services.
China and the United States are two leaders in AI industry. On the AI 100 list (2022) released by CB Insights, the number of companies in the United States ranks first, with more than 70 companies, followed by the United Kingdom, with 8 companies on the list. China and Canada both holds 5 companies on the list. According to data from the China Academy of Information and Communications Technology, the scale of China's core artificial intelligence industry reached ¥508 billion in 2022, a year-on-year increase of 18%. From 2013 to November 2022, the cumulative number of patent applications for artificial intelligence inventions in the world reached 729,000, and the cumulative number of applications in China reached 389,000, accounting for 53.4%. However, the Global Artificial Intelligence Innovation Index Report 2021 released by the China Institute of Scientific and Technological Information shows that the overall strength of the United States is still far ahead. The number of artificial intelligence companies in the United States is about 4,670, while China has only 880. China's data center is less than 1/20 of that of the United States.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Artificial Intelligence in Drug Discovery and Development market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
IBM
Exscientia
Google(Alphabet)
Microsoft
Atomwise
Schrodinger
Aitia
Insilico Medicine
NVIDIA
XtalPi
BPGbio
Owkin
CytoReason
Deep Genomics
Cloud Pharmaceuticals
BenevolentAI
Cyclica
Verge Genomics
Valo Health
Envisagenics
Euretos
BioAge Labs
Iktos
BioSymetrics
Evaxion Biotech
Aria Pharmaceuticals, Inc
Segment by Type
Hardware
Software
Service
Segment by Application
Early Drug Discovery
Preclinical Phase
Clinical Phase
Regulatory Approval
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Artificial Intelligence in Drug Discovery and Development report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence in Drug Discovery and Development Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Hardware
1.2.3 Software
1.2.4 Service
1.3 Market by Application
1.3.1 Global Artificial Intelligence in Drug Discovery and Development Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Early Drug Discovery
1.3.3 Preclinical Phase
1.3.4 Clinical Phase
1.3.5 Regulatory Approval
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence in Drug Discovery and Development Market Perspective (2018-2029)
2.2 Artificial Intelligence in Drug Discovery and Development Growth Trends by Region
2.2.1 Global Artificial Intelligence in Drug Discovery and Development Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Intelligence in Drug Discovery and Development Historic Market Size by Region (2018-2023)
2.2.3 Artificial Intelligence in Drug Discovery and Development Forecasted Market Size by Region (2024-2029)
2.3 Artificial Intelligence in Drug Discovery and Development Market Dynamics
2.3.1 Artificial Intelligence in Drug Discovery and Development Industry Trends
2.3.2 Artificial Intelligence in Drug Discovery and Development Market Drivers
2.3.3 Artificial Intelligence in Drug Discovery and Development Market Challenges
2.3.4 Artificial Intelligence in Drug Discovery and Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence in Drug Discovery and Development Players by Revenue
3.1.1 Global Top Artificial Intelligence in Drug Discovery and Development Players by Revenue (2018-2023)
3.1.2 Global Artificial Intelligence in Drug Discovery and Development Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Intelligence in Drug Discovery and Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence in Drug Discovery and Development Revenue
3.4 Global Artificial Intelligence in Drug Discovery and Development Market Concentration Ratio
3.4.1 Global Artificial Intelligence in Drug Discovery and Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Drug Discovery and Development Revenue in 2022
3.5 Artificial Intelligence in Drug Discovery and Development Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence in Drug Discovery and Development Product Solution and Service
3.7 Date of Enter into Artificial Intelligence in Drug Discovery and Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence in Drug Discovery and Development Breakdown Data by Type
4.1 Global Artificial Intelligence in Drug Discovery and Development Historic Market Size by Type (2018-2023)
4.2 Global Artificial Intelligence in Drug Discovery and Development Forecasted Market Size by Type (2024-2029)
5 Artificial Intelligence in Drug Discovery and Development Breakdown Data by Application
5.1 Global Artificial Intelligence in Drug Discovery and Development Historic Market Size by Application (2018-2023)
5.2 Global Artificial Intelligence in Drug Discovery and Development Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Intelligence in Drug Discovery and Development Market Size (2018-2029)
6.2 North America Artificial Intelligence in Drug Discovery and Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Intelligence in Drug Discovery and Development Market Size by Country (2018-2023)
6.4 North America Artificial Intelligence in Drug Discovery and Development Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence in Drug Discovery and Development Market Size (2018-2029)
7.2 Europe Artificial Intelligence in Drug Discovery and Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Intelligence in Drug Discovery and Development Market Size by Country (2018-2023)
7.4 Europe Artificial Intelligence in Drug Discovery and Development Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence in Drug Discovery and Development Market Size (2018-2029)
8.2 Asia-Pacific Artificial Intelligence in Drug Discovery and Development Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Intelligence in Drug Discovery and Development Market Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Intelligence in Drug Discovery and Development Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence in Drug Discovery and Development Market Size (2018-2029)
9.2 Latin America Artificial Intelligence in Drug Discovery and Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Intelligence in Drug Discovery and Development Market Size by Country (2018-2023)
9.4 Latin America Artificial Intelligence in Drug Discovery and Development Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence in Drug Discovery and Development Market Size (2018-2029)
10.2 Middle East & Africa Artificial Intelligence in Drug Discovery and Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Intelligence in Drug Discovery and Development Market Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Intelligence in Drug Discovery and Development Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Detail
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence in Drug Discovery and Development Introduction
11.1.4 IBM Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.1.5 IBM Recent Development
11.2 Exscientia
11.2.1 Exscientia Company Detail
11.2.2 Exscientia Business Overview
11.2.3 Exscientia Artificial Intelligence in Drug Discovery and Development Introduction
11.2.4 Exscientia Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.2.5 Exscientia Recent Development
11.3 Google(Alphabet)
11.3.1 Google(Alphabet) Company Detail
11.3.2 Google(Alphabet) Business Overview
11.3.3 Google(Alphabet) Artificial Intelligence in Drug Discovery and Development Introduction
11.3.4 Google(Alphabet) Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.3.5 Google(Alphabet) Recent Development
11.4 Microsoft
11.4.1 Microsoft Company Detail
11.4.2 Microsoft Business Overview
11.4.3 Microsoft Artificial Intelligence in Drug Discovery and Development Introduction
11.4.4 Microsoft Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.4.5 Microsoft Recent Development
11.5 Atomwise
11.5.1 Atomwise Company Detail
11.5.2 Atomwise Business Overview
11.5.3 Atomwise Artificial Intelligence in Drug Discovery and Development Introduction
11.5.4 Atomwise Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.5.5 Atomwise Recent Development
11.6 Schrodinger
11.6.1 Schrodinger Company Detail
11.6.2 Schrodinger Business Overview
11.6.3 Schrodinger Artificial Intelligence in Drug Discovery and Development Introduction
11.6.4 Schrodinger Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.6.5 Schrodinger Recent Development
11.7 Aitia
11.7.1 Aitia Company Detail
11.7.2 Aitia Business Overview
11.7.3 Aitia Artificial Intelligence in Drug Discovery and Development Introduction
11.7.4 Aitia Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.7.5 Aitia Recent Development
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Detail
11.8.2 Insilico Medicine Business Overview
11.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery and Development Introduction
11.8.4 Insilico Medicine Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.8.5 Insilico Medicine Recent Development
11.9 NVIDIA
11.9.1 NVIDIA Company Detail
11.9.2 NVIDIA Business Overview
11.9.3 NVIDIA Artificial Intelligence in Drug Discovery and Development Introduction
11.9.4 NVIDIA Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.9.5 NVIDIA Recent Development
11.10 XtalPi
11.10.1 XtalPi Company Detail
11.10.2 XtalPi Business Overview
11.10.3 XtalPi Artificial Intelligence in Drug Discovery and Development Introduction
11.10.4 XtalPi Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.10.5 XtalPi Recent Development
11.11 BPGbio
11.11.1 BPGbio Company Detail
11.11.2 BPGbio Business Overview
11.11.3 BPGbio Artificial Intelligence in Drug Discovery and Development Introduction
11.11.4 BPGbio Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.11.5 BPGbio Recent Development
11.12 Owkin
11.12.1 Owkin Company Detail
11.12.2 Owkin Business Overview
11.12.3 Owkin Artificial Intelligence in Drug Discovery and Development Introduction
11.12.4 Owkin Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.12.5 Owkin Recent Development
11.13 CytoReason
11.13.1 CytoReason Company Detail
11.13.2 CytoReason Business Overview
11.13.3 CytoReason Artificial Intelligence in Drug Discovery and Development Introduction
11.13.4 CytoReason Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.13.5 CytoReason Recent Development
11.14 Deep Genomics
11.14.1 Deep Genomics Company Detail
11.14.2 Deep Genomics Business Overview
11.14.3 Deep Genomics Artificial Intelligence in Drug Discovery and Development Introduction
11.14.4 Deep Genomics Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.14.5 Deep Genomics Recent Development
11.15 Cloud Pharmaceuticals
11.15.1 Cloud Pharmaceuticals Company Detail
11.15.2 Cloud Pharmaceuticals Business Overview
11.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery and Development Introduction
11.15.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.15.5 Cloud Pharmaceuticals Recent Development
11.16 BenevolentAI
11.16.1 BenevolentAI Company Detail
11.16.2 BenevolentAI Business Overview
11.16.3 BenevolentAI Artificial Intelligence in Drug Discovery and Development Introduction
11.16.4 BenevolentAI Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.16.5 BenevolentAI Recent Development
11.17 Cyclica
11.17.1 Cyclica Company Detail
11.17.2 Cyclica Business Overview
11.17.3 Cyclica Artificial Intelligence in Drug Discovery and Development Introduction
11.17.4 Cyclica Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.17.5 Cyclica Recent Development
11.18 Verge Genomics
11.18.1 Verge Genomics Company Detail
11.18.2 Verge Genomics Business Overview
11.18.3 Verge Genomics Artificial Intelligence in Drug Discovery and Development Introduction
11.18.4 Verge Genomics Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.18.5 Verge Genomics Recent Development
11.19 Valo Health
11.19.1 Valo Health Company Detail
11.19.2 Valo Health Business Overview
11.19.3 Valo Health Artificial Intelligence in Drug Discovery and Development Introduction
11.19.4 Valo Health Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.19.5 Valo Health Recent Development
11.20 Envisagenics
11.20.1 Envisagenics Company Detail
11.20.2 Envisagenics Business Overview
11.20.3 Envisagenics Artificial Intelligence in Drug Discovery and Development Introduction
11.20.4 Envisagenics Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.20.5 Envisagenics Recent Development
11.21 Euretos
11.21.1 Euretos Company Detail
11.21.2 Euretos Business Overview
11.21.3 Euretos Artificial Intelligence in Drug Discovery and Development Introduction
11.21.4 Euretos Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.21.5 Euretos Recent Development
11.22 BioAge Labs
11.22.1 BioAge Labs Company Detail
11.22.2 BioAge Labs Business Overview
11.22.3 BioAge Labs Artificial Intelligence in Drug Discovery and Development Introduction
11.22.4 BioAge Labs Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.22.5 BioAge Labs Recent Development
11.23 Iktos
11.23.1 Iktos Company Detail
11.23.2 Iktos Business Overview
11.23.3 Iktos Artificial Intelligence in Drug Discovery and Development Introduction
11.23.4 Iktos Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.23.5 Iktos Recent Development
11.24 BioSymetrics
11.24.1 BioSymetrics Company Detail
11.24.2 BioSymetrics Business Overview
11.24.3 BioSymetrics Artificial Intelligence in Drug Discovery and Development Introduction
11.24.4 BioSymetrics Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.24.5 BioSymetrics Recent Development
11.25 Evaxion Biotech
11.25.1 Evaxion Biotech Company Detail
11.25.2 Evaxion Biotech Business Overview
11.25.3 Evaxion Biotech Artificial Intelligence in Drug Discovery and Development Introduction
11.25.4 Evaxion Biotech Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.25.5 Evaxion Biotech Recent Development
11.26 Aria Pharmaceuticals, Inc
11.26.1 Aria Pharmaceuticals, Inc Company Detail
11.26.2 Aria Pharmaceuticals, Inc Business Overview
11.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery and Development Introduction
11.26.4 Aria Pharmaceuticals, Inc Revenue in Artificial Intelligence in Drug Discovery and Development Business (2018-2023)
11.26.5 Aria Pharmaceuticals, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
